BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li R, Liu X, Zhou XJ, Chen X, Li JP, Yin YH, Qu YQ. Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma. Front Oncol 2020;10:1588. [PMID: 33014809 DOI: 10.3389/fonc.2020.01588] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Zou B, Zhao J, Liang J, She Z, Zhou W, Lin S, Tian L, Luo W, He F. A novel DNA damage repair-related signature for predicting prognositc and treatment response in non-small lung cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.961274] [Reference Citation Analysis]
2 Long M, Zhou Z, Wei X, Lin Q, Qiu M, Zhou Y, Chen P, Jiang Y, Wen Q, Liu Y, Li R, Zhou X, Yu H. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1023349] [Reference Citation Analysis]
3 Cao Y, Zhu H, Shen H, Liu D, Li Z, Shang H, Du H, Wang Y, Ye J, Want M. Prognostic Index for Nonsmall Cell Lung Cancer Based on Immune-Related Genes Expression. BioMed Research International 2022;2022:1-10. [DOI: 10.1155/2022/4779811] [Reference Citation Analysis]
4 Zhang M, Li J, Lin W, Qi L, Yao C, Zheng Z, Chen C, Duan S, Qi Y. EPAS1 Promoter Hypermethylation is a Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer. Genet Test Mol Biomarkers 2022. [PMID: 35920832 DOI: 10.1089/gtmb.2021.0305] [Reference Citation Analysis]
5 Jiang W, Xie N, Xu C. Characterization of a prognostic model for lung squamous cell carcinoma based on eight stemness index-related genes. BMC Pulm Med 2022;22:224. [PMID: 35676660 DOI: 10.1186/s12890-022-02011-0] [Reference Citation Analysis]
6 Lin D, Zhao W, Yang J, Wang H, Zhang H. Integrative Analysis of Biomarkers and Mechanisms in Adamantinomatous Craniopharyngioma. Front Genet 2022;13:830793. [DOI: 10.3389/fgene.2022.830793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Jiang Y, Xi Y, Li Y, Zuo Z, Zeng C, Fan J, Zhang D, Tao H, Guo Y. Ethanol promoting the upregulation of C-X-C Motif Chemokine Ligand 1(CXCL1) and C-X-C Motif Chemokine Ligand 6(CXCL6) in models of early alcoholic liver disease. Bioengineered 2022;13:4688-701. [PMID: 35156518 DOI: 10.1080/21655979.2022.2030557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Qian H, Lv X, Song Q, Su R, Xie T, Wu D, Chang R, Chen L, Yang Y, Chen Y, Wang X, Ru Y, Shang L, Guo X. Association of dysbindin expression with individualized postoperative prognosis and chemotherapy benefit among patients with gastric adenocarcinoma. J Cancer 2021;12:6740-8. [PMID: 34659563 DOI: 10.7150/jca.60576] [Reference Citation Analysis]
9 Jia R, Sui Z, Zhang H, Yu Z. Identification and Validation of Immune-Related Gene Signature for Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma. Front Mol Biosci 2021;8:679031. [PMID: 34109216 DOI: 10.3389/fmolb.2021.679031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
10 Yu Y, Ren K. Five long non-coding RNAs establish a prognostic nomogram and construct a competing endogenous RNA network in the progression of non-small cell lung cancer. BMC Cancer 2021;21:457. [PMID: 33892664 DOI: 10.1186/s12885-021-08207-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]